CC-0. https://www.freeimageslive.co.uk/free_stock_image/syringe-jpg
CC-0. https://www.freeimageslive.co.uk/free_stock_image/syringe-jpg

Sharing needles common among injecting drug users, even those treated for hep C

Embargoed until: Publicly released:
Peer-reviewed: This work was reviewed and scrutinised by relevant independent experts.

Case study: A study involving observations of a single patient or group of patients.

Survey: A study based solely on people’s responses to a series of questions.

People: This is a study based on research using people.

Australian experts say needle and syringe sharing is common among injecting drug users who attend drug treatment clinics and needle and syringe programs.  They surveyed 1,555 Aussies who had injected drugs in the past month, and found 432 (28%) had shared needles or syringes with other users, and 276 (18%) had used a needle or syringe after it had been used by someone else (receptive sharing). Younger people, those recently released from prison, heavier users, and those with insecure housing were the most likely to have engaged in receptive sharing. Among 560 people who had been treated for hepatitis C, 87 (16%) reported receptive sharing, with younger users and more frequent users the most likely to have used someone else's needle or syringe after them. Further research is needed to help curb risky needle-sharing behaviour among injecting drug users and optimise treatment for hepatitis C, the researchers conclude.

Journal/conference: Drug & Alcohol Review

Link to research (DOI): 10.1111/dar.13828

Organisation/s: Kirby Institute, UNSW Sydney, National Drug and Alcohol Research Centre (NDARC), The University of New South Wales

Funder: National Health and Medical Research Council, Grant/Award Number: 1103165; New South Wales Health; Merck Sharp and Dohme Australia; Cepheid

Attachments:

Note: Not all attachments are visible to the general public

  • Wiley
    Web page
    The URL will go live after the embargo ends

News for:

Australia
NSW

Media contact details for this story are only visible to registered journalists.